Fujimaki K - Search Results

1

Clinical features and outcome in HCV-positive aggressive non-Hodgkin's lymphoma.

Tomita N, Kodama F, Takabayashi M, Kawano T, Yamaji S, Fujimaki K, Fujisawa S, Kanamori H, Motomura S, Ishigatsubo Y. Tomita N, et al. Among authors: fujimaki k. Leuk Lymphoma. 2003 Jul;44(7):1159-64. doi: 10.1080/1042819031000083055. Leuk Lymphoma. 2003. PMID: 12916868

2

Interstitial pneumonia induced by combination therapy with low-dose cytarabine and granulocyte colony-stimulating factor.

Motomura S, Fujisawa S, Fujimaki K, Mohri H, Okubo T. Motomura S, et al. Among authors: fujimaki k. Am J Hematol. 1995 Aug;49(4):364. doi: 10.1002/ajh.2830490429. Am J Hematol. 1995. PMID: 7543731 No abstract available.

3

[Intermittent-dose ara-C/daunomycin therapy combined with cyclosporin-A and G-CSF led to a fourth remission in a patient with acute promyelocytic leukemia].

Motomura S, Fujisawa S, Anzai S, Fujimaki K, Hattori M, Fukawa H, Okubo T. Motomura S, et al. Among authors: fujimaki k. Rinsho Ketsueki. 1995 Aug;36(8):762-7. Rinsho Ketsueki. 1995. PMID: 7563610 Japanese.

4

Translocation 21;22 may be involved in control of differentiation in erythroleukemia.

Fujisawa S, Motomura S, Fujimaki K, Okubo T. Fujisawa S, et al. Among authors: fujimaki k. Am J Hematol. 1996 May;52(1):65. doi: 10.1002/1096-8652(199605)52:1<65::aid-ajh2830520103>3.0.co;2-y. Am J Hematol. 1996. PMID: 8638620 Free article. No abstract available.

5

Hematologic benefits of 1-hydroxyvitamin D3 in an elderly patient with chronic myelodysplastic syndrome.

Motomura S, Fujisawa S, Tsunooka S, Fujimaki K, Mohri H, Okubo T. Motomura S, et al. Among authors: fujimaki k. Am J Hematol. 1996 Oct;53(2):143-4. doi: 10.1002/(SICI)1096-8652(199610)53:2<143::AID-AJH17>3.0.CO;2-G. Am J Hematol. 1996. PMID: 8892744 Free article. No abstract available.

6

Chronic myelocytic leukemia following ulcerative colitis.

Fujisawa S, Motomura S, Fujimaki K, Mohri H, Okubo T. Fujisawa S, et al. Among authors: fujimaki k. Int J Hematol. 1996 Apr;63(3):241-2. Int J Hematol. 1996. PMID: 8936338 Review. No abstract available.

7

DNA topoisomerase II inhibitors enhance random integration of transfected vectors into human chromosomes.

Fujimaki K, Aratani Y, Fujisawa S, Motomura S, Okubo T, Koyama H. Fujimaki K, et al. Somat Cell Mol Genet. 1996 Jul;22(4):279-90. doi: 10.1007/BF02369567. Somat Cell Mol Genet. 1996. PMID: 9000172

8

Translocation (3;21)(q26;q22) in de novo acute myelogenous leukemia.

Motomura S, Fujisawa S, Tsunooka S, Fujimaki K, Harano H, Mohri H, Okubo T, Fujita H, Maruta A, Kodama F. Motomura S, et al. Among authors: fujimaki k. Leukemia. 1997 Jan;11(1):172-3. doi: 10.1038/sj.leu.2400533. Leukemia. 1997. PMID: 9001437 No abstract available.

9

Effect of low-dose 1-hydroxyvitamin D3 in a patient with myelodysplasia after induction therapy for acute myelocytic leukemia.

Fujisawa S, Motomura S, Sakai R, Tomita N, Fujimaki K, Mohri H, Okubo T. Fujisawa S, et al. Among authors: fujimaki k. Anticancer Drugs. 1997 Jun;8(5):466-7. doi: 10.1097/00001813-199706000-00008. Anticancer Drugs. 1997. PMID: 9215609 No abstract available.

10

[Chronic myelogenous leukemia with long-term hypoplasia induced by alpha-interferon and hydroxyurea].

Motomura S, Sakai R, Tomita N, Fujimaki K, Hattori M, Fujisawa S, Mohri H, Takahashi N, Maruta A, Kodama F, Okubo T. Motomura S, et al. Among authors: fujimaki k. Rinsho Ketsueki. 1998 Apr;39(4):302-7. Rinsho Ketsueki. 1998. PMID: 9597898 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters